Altos Consulting Group

Now Booking Free 30-minute strategy call For clinic founders and owners See if you qualify

What Happens When a Clinic Gets an FDA Warning Letter

Nova S.

Published on: 15/10/2026

What happens when a clinic receives an FDA warning letter — the process, warning versus untitled letters, the public record consequences, response requirements, and what follows.

FDA warning letter clinicFDA untitled letterclinic FDA inspectionwarning letter responseFDA enforcement clinicmedical clinic regulatory actionFDA warning letter response windowunapproved new drug violationunlicensed biological productFDA seizure injunctionmedical board licensure action

Why Regenerative Clinics Get Their Ad Accounts Banned

Nova S.

Published on: 12/10/2026

Why regenerative health clinics get their ad accounts banned — healthcare advertising certification, restricted drug terms, personalized advertising limits, and what compliant creative looks like.

clinic ad account bannedmedical clinic advertising policyGoogle Ads healthcare restrictionsTRT advertising rulesclinic ad disapprovalhealthcare advertising compliancehealthcare advertiser certificationrestricted drug terms policyhealth advertising personalization restrictionsclinic ad creative compliancepatient acquisition channel risk

New Earnings Claims and the FTC: Why Honest Consultants Won't Promise You IncomePost

Nova S.

Published on: 08/10/2026

Why legitimate clinic consultants will not guarantee income — what the FTC requires for earnings claims, recent enforcement actions, and the questions to ask before signing.

clinic consultant income guaranteeare clinic consultants a scamFTC earnings claimsmedical clinic franchise income claimsevaluating clinic consultantsclinic startup income promisesFTC Business Opportunity Ruleearnings claim substantiationdeceptive income claims enforcementclinic consulting due diligencebusiness opportunity disclosure

Exosomes and the FDA: What Every Clinic Owner Needs to Know

Nova S.

Published on: 05/10/2026

Are exosomes FDA approved? The regulatory status of exosome products, why common workarounds fail, the enforcement record, and why ACG steers clients away from exosome therapy entirely.

are exosomes FDA approvedexosome therapy legalexosome clinic FDA warningexosome injections regulationis exosome therapy legalexosome products approval statusFDA public safety notification exosomesunapproved biologic clinicexosome warning letterextracellular vesicle regulationregenerative medicine enforcement